-
inhibitor (TKI)
versus intercalated TKI with
chemotherapy for EGFR-mutated
nonsmall cell lung cancer". ERJ Open Research. 8 (4): 00239–2022. doi:10.1183/23120541...
- Pie
chart showing incidences of
nonsmall-cell lung
cancers as
compared to small-cell
carcinoma shown at right, with
fractions of
smokers versus nonsmokers...
-
found a
presence of an HPV
infection in 16.4% of the
subjects affected by
nonsmall cell lung cancer, but in none of the controls. The
reported average frequencies...
-
Schmittel A, Reck M (March 2014). "First-line
treatment of EGFR-mutated
nonsmall cell lung cancer:
critical review on
study methodology".
European Respiratory...
-
cells to
lymph nodes. CCR7 is
expressed by
various cancer cells, such as
nonsmall lung cancer,
gastric cancer and
oesophageal cancer.
Expression of CCR7...
-
after first-line cisplatin-pemetrexed-bevacizumab for
advanced nonsquamous nonsmall-cell lung cancer:
updated survival analysis of the
AVAPERL (MO22089) randomized...
- of
nonsmall cell lung carcinomas,
while overexpression of IL-33
resulted in
increased growth.
Blocking of IL-33
reduced the
growth of
human nonsmall cell...
- miR-374a as a
prognostic marker for
survival in
patients with early-stage
nonsmall cell lung cancer". Genes,
Chromosomes & Cancer. 50 (10): 812–22. doi:10...
-
inhibitor (TKI)
versus intercalated TKI with
chemotherapy for EGFR-mutated
nonsmall cell lung cancer". ERJ Open Research. 8 (4): 00239–2022. doi:10.1183/23120541...
- models.
Clinical trials with HSP
inhibitors have also been reported. For
nonsmall-cell lung cancer, HSP27, HSP70, and HSP90
inhibitors are
under investigation...